-transparent.png){kind=logo}
Although both continuous haemofiltration and continuous haemodialysis are techniques routinely employed in the management of critically ill patients, deciding on a drug dosing regimen is often difficult. This article highlights the factors influencing drug removal by both processes, the difficulties associated with the interpretation of research in this area and offers a number of approaches which can be used when selecting a dosing regimen for a patient receiving one of these therapies.
Related Publications
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
September 1994,
The Journal of the Association of Physicians of India,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
June 1993,
The Journal of the Association of Physicians of India,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1994,
Intensive care medicine,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1988,
Lancet (London, England),
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1992,
International urology and nephrology,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1988,
Medical toxicology and adverse drug experience,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
April 2018,
Journal of clinical pharmacy and therapeutics,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1983,
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1995,
Anaesthesia,
J G Davies, and
J C Kingswood, and
P Sharpstone, and
M K Street
January 1985,
Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress,
